SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the third quarter 2025 and provided an update on the company’s recent developments.
The Global Poultry Medicine Market is poised for growth due to increasing demand for poultry meat and eggs, advancements in veterinary medicine, and a shift towards antibiotic-free production.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback